Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanyi Meng

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Cellular & Molecular Immunology|May 28, 2026
Macrophage USP9X attenuates colitis by restricting oncostatin M production via K27-linked deubiquitination of STAT1Tao Zhang, Fanyi Meng, Wenjing Zhao, et al.
Oncotarget|September 19, 2015
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patientsXuejie Jiang, Zhixiang Wang, Bingjie Ding, et al.
Nature Communications|July 1, 2026
RNF2 mediates H2A ubiquitination to promote colitis via suppressing monocyte-macrophage transition in miceFanyi Meng, Tao Zhang, Xiangyu Meng, et al.
Investigational New Drugs|January 15, 2022
Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trialDaobin Zhou, Wei Xu, Hongbing Ma, et al.
International Journal of Hematology|March 11, 2015
Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairmentDao-bin Zhou, Li Yu, Xin Du, et al.
Journal of Hematology & Oncology|June 21, 2013
A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trialJian Hou, Xin Du, Jie Jin, et al.
Gut Microbes|July 28, 2024
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfationMengfan Li, Yiyun Ding, Jingge Wei, et al.
Blood|March 14, 2015
Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchinaJianxiang Wang, Zhi-Xiang Shen, Giuseppe Saglio, et al.
Cell Death & Disease|August 3, 2023
FDW028, a novel FUT8 inhibitor, impels lysosomal proteolysis of B7-H3 via chaperone-mediated autophagy pathway and exhibits potent efficacy against metastatic colorectal cancerMengmeng Wang, Zhoudong Zhang, Mengxi Chen, et al.
Leukemia|February 19, 2020
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study GroupHuangming Hong, Yexiong Li, Soon Thye Lim, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Cellular & Molecular Immunology|May 28, 2026
Macrophage USP9X attenuates colitis by restricting oncostatin M production via K27-linked deubiquitination of STAT1Tao Zhang, Fanyi Meng, Wenjing Zhao, et al.
Oncotarget|September 19, 2015
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patientsXuejie Jiang, Zhixiang Wang, Bingjie Ding, et al.
Nature Communications|July 1, 2026
RNF2 mediates H2A ubiquitination to promote colitis via suppressing monocyte-macrophage transition in miceFanyi Meng, Tao Zhang, Xiangyu Meng, et al.
Investigational New Drugs|January 15, 2022
Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trialDaobin Zhou, Wei Xu, Hongbing Ma, et al.
International Journal of Hematology|March 11, 2015
Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairmentDao-bin Zhou, Li Yu, Xin Du, et al.
Journal of Hematology & Oncology|June 21, 2013
A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: the MM-021 trialJian Hou, Xin Du, Jie Jin, et al.
Gut Microbes|July 28, 2024
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfationMengfan Li, Yiyun Ding, Jingge Wei, et al.
Blood|March 14, 2015
Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchinaJianxiang Wang, Zhi-Xiang Shen, Giuseppe Saglio, et al.
Cell Death & Disease|August 3, 2023
FDW028, a novel FUT8 inhibitor, impels lysosomal proteolysis of B7-H3 via chaperone-mediated autophagy pathway and exhibits potent efficacy against metastatic colorectal cancerMengmeng Wang, Zhoudong Zhang, Mengxi Chen, et al.
Leukemia|February 19, 2020
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study GroupHuangming Hong, Yexiong Li, Soon Thye Lim, et al.
Pageof 12